WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer
Status:
Completed
Trial end date:
2021-02-03
Target enrollment:
Participant gender:
Summary
This trial is to determine what dose of a drug called AZD1775 can safely be given in
combination with cisplatin before surgery and with chemo-radiotherapy after surgery in
patients with Head and Neck Cancer. The Investigators will also get some preliminary
information regarding the effectiveness of this combined treatment.